Alemtuzumab Markedly Reduces Chronic GVHD Without Affecting Overall Survival in Reduced-Intensity Conditioning Sibling Allo-SCT for Adults With AML

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2008.375
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search